We are live on ! Find out more
MCA

Martin Capital Advisors Portfolio holdings

AUM $191M
1-Year Est. Return 42.42%
This Fund
S&P 500
This Quarter Est. Return
+28.49%
1 Year Est. Return
+42.42%
3 Year Est. Return
+117.16%
5 Year Est. Return
10 Year Est. Return
AUM
$191M
AUM Growth
+$32.4M
Cap. Flow
+$3.61M
Cap. Flow %
1.89%
Top 10 Hldgs %
58.17%
Holding
78
New
5
Increased
34
Reduced
16
Closed
1

Top Buys

Rank Stock Value
1
AXON
Axon Enterprise
AXON
+$272K
2
ADI icon
Analog Devices
ADI
+$209K
3
DELL icon
Dell
DELL
+$184K
4
AMD icon
Advanced Micro Devices
AMD
+$168K
5
ASML icon
ASML
ASML
+$167K

Top Sells

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$237K
2
USPH icon
US Physical Therapy
USPH
+$72K
3
TSCO icon
Tractor Supply
TSCO
+$54.1K
4
QQQ icon
Invesco QQQ Trust
QQQ
+$49.5K
5
PYPL icon
PayPal
PYPL
+$27.5K

Sector Composition

Rank Sector Weight
1 Technology 49.02%
2 Healthcare 10.03%
3 Consumer Discretionary 9.89%
4 Financials 9.85%
5 Communication Services 4.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IGSB icon
76
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$208K 0.11%
3,960
IPGP icon
77
IPG Photonics
IPGP
$3.6B
$204K 0.11%
1,741
-14
-0.8% -$1.61K
ZTS icon
78
Zoetis
ZTS
$31.9B
-2,003
Closed -$237K

Similar funds

Martin Capital Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Martin Capital Advisors held 78 positions worth $191M, up 20% from $158M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Martin Capital Advisors's Q2 2026 filing shows 5 new, 34 increased, 16 reduced and 1 closed positions. Its largest new stake was Axon Enterprise: 651 shares worth $365K. The largest sale was Zoetis, an estimated $237K.

By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 45% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Martin Capital Advisors's largest Q2 2026 buy was Axon Enterprise: 651 shares worth $365K.
  • Martin Capital Advisors added most to Advanced Micro Devices in Q2 2026, an estimated $168K increase.
  • Martin Capital Advisors's biggest Q2 2026 reduction was US Physical Therapy, cutting an estimated $72K.
  • Martin Capital Advisors fully exited Zoetis in Q2 2026, selling an estimated $237K.
  • Martin Capital Advisors's ten largest holdings make up 58% of its $191M portfolio in Q2 2026.
  • Martin Capital Advisors opened 5 new positions and closed 1 in Q2 2026.
  • Martin Capital Advisors's portfolio value rose 20% quarter-over-quarter to $191M.

Based on Martin Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.